home / stock / kne:cc / kne:cc quote
Last: | $0.095 |
---|---|
Change Percent: | -5.0% |
Open: | $0.1 |
Close: | $0.095 |
High: | $0.1 |
Low: | $0.095 |
Volume: | 12,000 |
Last Trade Date Time: | 05/06/2022 04:55:56 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.095 | $0.1 | $0.095 | $0.1 | $0.095 | 12,000 | 05-06-2022 |
$0.1 | $0.1 | $0.1 | $0.1 | $0.1 | 9,600 | 05-05-2022 |
$0.09 | $0.09 | $0.09 | $0.09 | $0.09 | 9,000 | 05-04-2022 |
$0.085 | $0.09 | $0.085 | $0.09 | $0.085 | 37,000 | 05-03-2022 |
$0.085 | $0.095 | $0.085 | $0.095 | $0.075 | 1,224,118 | 05-02-2022 |
$0.095 | $0.095 | $0.095 | $0.095 | $0.095 | 15,000 | 04-29-2022 |
$0.095 | $0.095 | $0.095 | $0.095 | $0.095 | 1,800 | 04-28-2022 |
$0.095 | $0.105 | $0.095 | $0.105 | $0.095 | 13,598 | 04-27-2022 |
$0.1 | $0.09 | $0.1 | $0.1 | $0.09 | 87,801 | 04-26-2022 |
$0.085 | $0.09 | $0.085 | $0.09 | $0.085 | 385,000 | 04-25-2022 |
$0.09 | $0.1 | $0.09 | $0.1 | $0.09 | 181,552 | 04-22-2022 |
$0.095 | $0.105 | $0.095 | $0.105 | $0.095 | 315,251 | 04-21-2022 |
$0.1 | $0.1 | $0.1 | $0.1 | $0.1 | 30,000 | 04-20-2022 |
$0.1 | $0.105 | $0.1 | $0.105 | $0.1 | 185,000 | 04-19-2022 |
$0.105 | $0.11 | $0.105 | $0.11 | $0.105 | 77,895 | 04-18-2022 |
$0.11 | $0.105 | $0.11 | $0.11 | $0.105 | 291,500 | 04-15-2022 |
$0.11 | $0.105 | $0.11 | $0.11 | $0.105 | 291,500 | 04-14-2022 |
$0.11 | $0.11 | $0.11 | $0.11 | $0.11 | 12,001 | 04-13-2022 |
$0.11 | $0.115 | $0.11 | $0.12 | $0.11 | 139,500 | 04-12-2022 |
$0.11 | $0.11 | $0.11 | $0.115 | $0.11 | 30,000 | 04-11-2022 |
News, Short Squeeze, Breakout and More Instantly...
WINNIPEG, Manitoba, July 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has received ISO 13485:2016 Medical Device Single Audit Program (“MDSAP”) Quality Certification as a designer, de...
WINNIPEG, Manitoba, July 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed a worldwide license agreement with Arizona-based Omni Bioceutical Innovations Inc. (“Omni”) for its c...
WINNIPEG, Manitoba, June 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made its first commercial-scale sale of revyve™ Antimicrobial Wound Gel product (“revyve™”...